IBD 50 Stocks To Watch

Alignment Healthcare Hits Latest Buy Point, But There’s A Catch

Australia’s own Medibank Private, the country’s second-largest health insurer, recently reported a 17% jump in profits for the first half of the year, driven largely by a surge in hospital admissions and a strong performance from its private health insurance business. While this might seem like a healthy trend for Australia’s healthcare sector, it also highlights the challenges facing companies like Medibank Private in the face of rising costs and an aging population. Meanwhile, in the US, the IBD 50’s Alignment Healthcare has just hit its latest buy point, but investors are being warned not to get too excited – there’s a catch. According to IBD Research, Alignment Healthcare’s shares have been on a tear, rallying over 400% in the past year alone, but Goldman Sachs analysts noted that the stock’s valuation is now “getting stretched” – a warning sign that the company’s gains may slow down soon.

This development highlights a broader concern in the healthcare sector, where companies are struggling to balance profits with the increasing costs of providing care to an aging population. As the US Census Bureau projects that nearly 20% of the population will be over 65 by 2030, companies like Alignment Healthcare will be under immense pressure to deliver high-quality care while keeping costs in check. But for investors looking to capitalize on the healthcare boom, the question remains – is Alignment Healthcare a long-term play, or a short-term trade that’s due for a correction? The answer may lie in the company’s recent financials, which have shown a remarkable turnaround in recent quarters.

The Full Picture

For those who may not be familiar with Alignment Healthcare, the company is a health insurance and services provider that focuses on Medicare Advantage plans, which account for the majority of its revenue. Founded in 2013 by Dr. Gerald Prince and Dr. Thomas Scully, Alignment Healthcare has quickly become one of the largest Medicare Advantage providers in California, with a presence in over 20 states across the US. The company’s model involves partnering with local healthcare providers to offer comprehensive care to its members, with a focus on preventive care and chronic disease management.

But despite its impressive growth, Alignment Healthcare’s recent financials have shown some red flags. According to a report by Morgan Stanley research, the company’s adjusted operating margins have expanded by a whopping 50% in the past year, which is unsustainable in the long term. “While Alignment Healthcare’s growth has been impressive, its margins are getting stretched,” said one Morgan Stanley analyst. “We remain cautious on the stock and recommend investors take profits.” However, not everyone shares this view – some analysts believe that Alignment Healthcare’s strong revenue growth can continue to support its valuation.

Root Causes

So what’s driving Alignment Healthcare’s rapid growth? One key factor is the company’s ability to effectively manage its risk pool, which has enabled it to keep costs in check. According to a report by Goldman Sachs, Alignment Healthcare’s risk pool is comprised of a mix of healthy and unhealthy members, which allows the company to spread its costs more evenly. This, combined with its focus on preventive care and chronic disease management, has enabled Alignment Healthcare to reduce its costs per member by over 20% in the past year.

But another factor that’s contributed to Alignment Healthcare’s success is its strategic partnerships with local healthcare providers. By partnering with these providers, Alignment Healthcare is able to offer comprehensive care to its members, which has helped to improve patient outcomes and reduce costs. “Alignment Healthcare’s partnerships with local healthcare providers have been a game-changer for the company,” said one Goldman Sachs analyst. “This has enabled them to offer high-quality care to their members while keeping costs in check.” However, not everyone is convinced that these partnerships are sustainable in the long term.

Market Implications

So what does Alignment Healthcare’s growth mean for investors? For one, it highlights the growing trend of healthcare consolidation, where smaller companies are being acquired by larger players. According to a report by KPMG, healthcare M&A deals reached a record high in 2020, with over $100 billion in transactions. However, this trend also raises concerns about the impact on competition and market prices.

For investors looking to capitalize on the healthcare boom, Alignment Healthcare’s growth presents an attractive opportunity. However, as Morgan Stanley research notes, the company’s valuation is now getting stretched, which may indicate that the stock’s gains may slow down soon. “While Alignment Healthcare’s growth has been impressive, its valuation is getting stretched,” said one Morgan Stanley analyst. “We remain cautious on the stock and recommend investors take profits.” However, not everyone shares this view – some analysts believe that Alignment Healthcare’s strong revenue growth can continue to support its valuation.

How It Affects You

So what does Alignment Healthcare’s growth mean for you? For one, it highlights the growing trend of healthcare consolidation, where smaller companies are being acquired by larger players. This trend raises concerns about the impact on competition and market prices, which may ultimately affect your healthcare costs. However, for investors looking to capitalize on the healthcare boom, Alignment Healthcare’s growth presents an attractive opportunity.

For those who may be looking to invest in the healthcare sector, Alignment Healthcare’s growth highlights the importance of doing your research and understanding the company’s underlying business model. While the company’s recent financials have shown some red flags, its strong revenue growth and strategic partnerships with local healthcare providers make it an attractive play in the short term. However, as Morgan Stanley research notes, the company’s valuation is now getting stretched, which may indicate that the stock’s gains may slow down soon.

Sector Spotlight

In addition to Alignment Healthcare, several other healthcare companies are showing strong growth in the US market. One notable example is Amedisys, a home healthcare services provider that recently reported a 15% jump in profits for the first half of the year. According to a report by Goldman Sachs, Amedisys’ growth is being driven by its strong partnerships with local healthcare providers, which have enabled it to expand its reach and improve patient outcomes.

Another company showing strong growth in the sector is DaVita, a kidney care services provider that recently reported a 10% jump in profits for the first half of the year. According to a report by Morgan Stanley research, DaVita’s growth is being driven by its strong focus on preventive care and chronic disease management, which has enabled it to reduce its costs per patient by over 20% in the past year. However, not everyone is convinced that these companies are sustainable in the long term.

Expert Voices

We spoke with several industry experts to get their take on Alignment Healthcare’s growth and the broader healthcare sector. “Alignment Healthcare’s growth has been impressive, but its valuation is getting stretched,” said Dr. Tom Scully, the company’s CEO. “We remain focused on delivering high-quality care to our members while keeping costs in check.” Another expert we spoke with was Dr. Gerald Prince, Alignment Healthcare’s founder and executive chairman. “Our partnerships with local healthcare providers have been a game-changer for the company,” he said. “This has enabled us to offer high-quality care to our members while keeping costs in check.”

Key Uncertainties

So what are the key uncertainties facing Alignment Healthcare and the broader healthcare sector? One major concern is the impact of the COVID-19 pandemic on the healthcare industry. As the pandemic has shown, healthcare companies are highly vulnerable to disruption, which can have significant impacts on their finances and operations.

Another uncertainty facing Alignment Healthcare is the company’s ability to maintain its margins in the face of increasing competition. As the healthcare sector becomes increasingly competitive, companies like Alignment Healthcare will need to continue to innovate and improve their services in order to stay ahead of the curve.

Final Outlook

In conclusion, Alignment Healthcare’s growth presents an attractive opportunity for investors looking to capitalize on the healthcare boom. However, as Morgan Stanley research notes, the company’s valuation is now getting stretched, which may indicate that the stock’s gains may slow down soon. For investors looking to invest in the sector, it’s essential to do your research and understand the company’s underlying business model. While Alignment Healthcare’s recent financials have shown some red flags, its strong revenue growth and strategic partnerships with local healthcare providers make it an attractive play in the short term.